MedPath
HSA Approval

ESTELLE-35 TABLET

SIN12117P

ESTELLE-35 TABLET

ESTELLE-35 TABLET

October 31, 2002

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

G03HB01

cyproterone and estrogen

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

DOUGLAS PHARMACEUTICALS LTD

Active Ingredients

ETHINYLOESTRADIOL

0.035 mg

Ethinylestradiol

CYPROTERONE ACETATE

2 mg

Cyproterone acetate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ESTELLE-35 TABLET - HSA Approval | MedPath